| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | cytoplasmic region | 1.72e-05 | 360 | 66 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 6.25e-05 | 317 | 66 | 7 | GO:0032838 | |
| GeneOntologyCellularComponent | axon cytoplasm | 6.34e-05 | 68 | 66 | 4 | GO:1904115 | |
| GeneOntologyCellularComponent | growth cone | 1.23e-04 | 245 | 66 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.47e-04 | 253 | 66 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | synaptic cleft | 1.53e-04 | 33 | 66 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 4.07e-04 | 110 | 66 | 4 | GO:0120111 | |
| GeneOntologyCellularComponent | inner dynein arm | 4.35e-04 | 10 | 66 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | presynaptic active zone | 1.03e-03 | 141 | 66 | 4 | GO:0048786 | |
| Domain | SNO | 1.27e-05 | 2 | 67 | 2 | IPR026741 | |
| Domain | SBNO_Helicase_C_dom | 1.27e-05 | 2 | 67 | 2 | IPR026937 | |
| Domain | Helicase_C_4 | 1.27e-05 | 2 | 67 | 2 | PF13871 | |
| Domain | ARM-type_fold | 2.08e-04 | 339 | 67 | 7 | IPR016024 | |
| Domain | SynN | 4.49e-04 | 9 | 67 | 2 | SM00503 | |
| Domain | Syntaxin | 6.83e-04 | 11 | 67 | 2 | PF00804 | |
| Domain | Syntaxin_N | 8.18e-04 | 12 | 67 | 2 | IPR006011 | |
| Domain | Syntaxin/epimorphin_CS | 1.47e-03 | 16 | 67 | 2 | IPR006012 | |
| Domain | SYNTAXIN | 1.47e-03 | 16 | 67 | 2 | PS00914 | |
| Domain | SNARE | 2.55e-03 | 21 | 67 | 2 | PF05739 | |
| Domain | t_SNARE | 2.80e-03 | 22 | 67 | 2 | SM00397 | |
| Domain | ARM-like | 2.83e-03 | 270 | 67 | 5 | IPR011989 | |
| Domain | T_SNARE | 3.90e-03 | 26 | 67 | 2 | PS50192 | |
| Domain | T_SNARE_dom | 4.84e-03 | 29 | 67 | 2 | IPR000727 | |
| Pubmed | 1.48e-06 | 12 | 67 | 3 | 23395379 | ||
| Pubmed | TAOK2 ACADVL ACAT1 GUCY1B1 DOCK9 ATG2B ADGRB3 GRIN1 HUWE1 STX1B RYR2 MAPK8IP3 | 1.64e-06 | 1139 | 67 | 12 | 36417873 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RIF1 PBRM1 SBNO1 ACAT1 CCDC47 SUPT6H MTR NUP188 HUWE1 MDH1 THOC2 NONO DDX1 | 2.80e-06 | 1425 | 67 | 13 | 30948266 |
| Pubmed | Study of Strawberry Notch homolog 1 and 2 expression in human glioblastoma. | 3.66e-06 | 2 | 67 | 2 | 36695974 | |
| Pubmed | 3.66e-06 | 2 | 67 | 2 | 25193700 | ||
| Pubmed | Role for RIF1-interacting partner DDX1 in BLM recruitment to DNA double-strand breaks. | 3.66e-06 | 2 | 67 | 2 | 28544931 | |
| Pubmed | 7.82e-06 | 244 | 67 | 6 | 29884807 | ||
| Pubmed | Cellular and circuit models of increased resting-state network gamma activity in schizophrenia. | 1.10e-05 | 3 | 67 | 2 | 26577758 | |
| Pubmed | 1.10e-05 | 3 | 67 | 2 | 34014261 | ||
| Pubmed | The BAH domain of BAF180 is required for PCNA ubiquitination. | 1.10e-05 | 3 | 67 | 2 | 26117423 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.20e-05 | 153 | 67 | 5 | 26365490 | |
| Pubmed | 2.14e-05 | 606 | 67 | 8 | 36538041 | ||
| Pubmed | A mouse homologue of Strawberry Notch is transcriptionally regulated by Reelin signal. | 2.19e-05 | 4 | 67 | 2 | 17045962 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 2.40e-05 | 807 | 67 | 9 | 30575818 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 2.54e-05 | 1024 | 67 | 10 | 24711643 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RIF1 CCDC47 MTR NUP188 HUWE1 THOC2 USP1 NONO COPS5 DDX1 KPNA1 | 2.64e-05 | 1257 | 67 | 11 | 37317656 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 3.49e-05 | 847 | 67 | 9 | 35235311 | |
| Pubmed | 3.52e-05 | 650 | 67 | 8 | 38777146 | ||
| Pubmed | The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. | 3.58e-05 | 33 | 67 | 3 | 22357600 | |
| Pubmed | 3.64e-05 | 5 | 67 | 2 | 12900932 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 4.84e-05 | 497 | 67 | 7 | 36774506 | |
| Pubmed | 5.00e-05 | 104 | 67 | 4 | 10470851 | ||
| Pubmed | 5.15e-05 | 686 | 67 | 8 | 29987050 | ||
| Pubmed | Jab1 regulates Schwann cell proliferation and axonal sorting through p27. | 5.46e-05 | 6 | 67 | 2 | 24344238 | |
| Pubmed | ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2. | 5.49e-05 | 38 | 67 | 3 | 30629181 | |
| Pubmed | 7.40e-05 | 224 | 67 | 5 | 32941674 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RIF1 ACADVL SBNO1 CCDC47 SUPT6H AKAP13 HUWE1 MDH1 NONO DDX1 KPNA1 | 7.69e-05 | 1415 | 67 | 11 | 28515276 |
| Pubmed | 8.38e-05 | 230 | 67 | 5 | 35449600 | ||
| Pubmed | 9.02e-05 | 549 | 67 | 7 | 38280479 | ||
| Pubmed | 9.02e-05 | 121 | 67 | 4 | 22412018 | ||
| Pubmed | 1.19e-04 | 248 | 67 | 5 | 32963011 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.29e-04 | 582 | 67 | 7 | 20467437 | |
| Pubmed | 1.30e-04 | 9 | 67 | 2 | 21491143 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.31e-04 | 583 | 67 | 7 | 29844126 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.38e-04 | 588 | 67 | 7 | 38580884 | |
| Pubmed | 1.38e-04 | 1014 | 67 | 9 | 32416067 | ||
| Pubmed | 1.41e-04 | 52 | 67 | 3 | 19328558 | ||
| Pubmed | 1.56e-04 | 418 | 67 | 6 | 34709266 | ||
| Pubmed | 1.63e-04 | 10 | 67 | 2 | 18434328 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.80e-04 | 271 | 67 | 5 | 32433965 | |
| Pubmed | 1.83e-04 | 272 | 67 | 5 | 31010829 | ||
| Pubmed | Identification of new high affinity targets for Roquin based on structural conservation. | 1.99e-04 | 11 | 67 | 2 | 30295819 | |
| Pubmed | E3 ligase autoinhibition by C-degron mimicry maintains C-degron substrate fidelity. | 1.99e-04 | 11 | 67 | 2 | 36805027 | |
| Pubmed | Ribosomal protein L12 uses a distinct nuclear import pathway mediated by importin 11. | 1.99e-04 | 11 | 67 | 2 | 11809816 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 2.05e-04 | 1318 | 67 | 10 | 30463901 | |
| Pubmed | 2.27e-04 | 638 | 67 | 7 | 33239621 | ||
| Pubmed | K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation. | 2.38e-04 | 12 | 67 | 2 | 26390156 | |
| Pubmed | 2.38e-04 | 12 | 67 | 2 | 22960999 | ||
| Pubmed | Genome-wide association study of height and body mass index in Australian twin families. | 2.38e-04 | 12 | 67 | 2 | 20397748 | |
| Pubmed | 2.42e-04 | 645 | 67 | 7 | 25281560 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.43e-04 | 289 | 67 | 5 | 23752268 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.53e-04 | 457 | 67 | 6 | 32344865 | |
| Pubmed | 2.61e-04 | 653 | 67 | 7 | 22586326 | ||
| Pubmed | 2.81e-04 | 13 | 67 | 2 | 33374598 | ||
| Pubmed | 2.90e-04 | 469 | 67 | 6 | 27634302 | ||
| Pubmed | 2.90e-04 | 469 | 67 | 6 | 37314180 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.92e-04 | 665 | 67 | 7 | 30457570 | |
| Pubmed | 3.28e-04 | 14 | 67 | 2 | 19240213 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 3.51e-04 | 486 | 67 | 6 | 30940648 | |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | 3.86e-04 | 495 | 67 | 6 | 28581483 | |
| Pubmed | 3.95e-04 | 497 | 67 | 6 | 23414517 | ||
| Pubmed | 4.15e-04 | 325 | 67 | 5 | 36168628 | ||
| Pubmed | 4.20e-04 | 503 | 67 | 6 | 16964243 | ||
| Pubmed | 4.27e-04 | 327 | 67 | 5 | 34428256 | ||
| Pubmed | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. | 4.31e-04 | 16 | 67 | 2 | 16230076 | |
| Pubmed | 4.39e-04 | 183 | 67 | 4 | 36129980 | ||
| Pubmed | 4.51e-04 | 331 | 67 | 5 | 29199018 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 4.58e-04 | 332 | 67 | 5 | 32786267 | |
| Pubmed | 4.88e-04 | 17 | 67 | 2 | 24386095 | ||
| Pubmed | 4.88e-04 | 17 | 67 | 2 | 36352191 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.17e-04 | 341 | 67 | 5 | 32971831 | |
| Pubmed | 5.22e-04 | 733 | 67 | 7 | 34672954 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 5.34e-04 | 736 | 67 | 7 | 29676528 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | STX3 SUPT6H MYT1 AKAP13 HUWE1 PRDM15 COPS5 SBNO2 MAPK8IP3 KPNA1 | 5.38e-04 | 1489 | 67 | 10 | 28611215 |
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 12588844 | ||
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 24025402 | ||
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 14730302 | ||
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 19546860 | ||
| Pubmed | 5.48e-04 | 18 | 67 | 2 | 21998198 | ||
| Pubmed | Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. | 6.03e-04 | 85 | 67 | 3 | 19596235 | |
| Pubmed | 6.12e-04 | 19 | 67 | 2 | 28981898 | ||
| Pubmed | Role of the Pbrm1 subunit and the PBAF complex in Schwann cell development. | 6.12e-04 | 19 | 67 | 2 | 35173232 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 6.43e-04 | 358 | 67 | 5 | 32460013 | |
| Pubmed | 6.45e-04 | 87 | 67 | 3 | 12465718 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.48e-04 | 203 | 67 | 4 | 22083510 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 6.83e-04 | 1005 | 67 | 8 | 19615732 | |
| Pubmed | 6.84e-04 | 552 | 67 | 6 | 36293380 | ||
| Pubmed | 6.84e-04 | 206 | 67 | 4 | 22174317 | ||
| Pubmed | 7.12e-04 | 90 | 67 | 3 | 33087562 | ||
| Pubmed | Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system. | 7.50e-04 | 21 | 67 | 2 | 28880149 | |
| Pubmed | RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2. | 7.50e-04 | 21 | 67 | 2 | 31712577 | |
| Pubmed | Discovery and characterization of spontaneous mouse models of craniofacial dysmorphology. | 7.50e-04 | 21 | 67 | 2 | 26234751 | |
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 7.50e-04 | 21 | 67 | 2 | 22767514 | |
| Pubmed | 7.77e-04 | 1285 | 67 | 9 | 35914814 | ||
| Pubmed | 8.11e-04 | 377 | 67 | 5 | 25147182 | ||
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | 8.16e-04 | 571 | 67 | 6 | 37167062 | |
| Pubmed | 8.24e-04 | 22 | 67 | 2 | 35245678 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 8.31e-04 | 217 | 67 | 4 | 31685992 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 8.60e-04 | 219 | 67 | 4 | 31353912 | |
| Pubmed | 8.89e-04 | 221 | 67 | 4 | 31796584 | ||
| GeneFamily | Syntaxins | 7.11e-04 | 16 | 45 | 2 | 818 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 6.37e-07 | 389 | 67 | 9 | M6520 | |
| ToppCell | Healthy_donor-Platelet|Healthy_donor / disease group, cell group and cell class (v2) | 9.21e-06 | 187 | 67 | 5 | 9040ffa5c23913b9dc0205fa6227223c2a2847ae | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.45e-06 | 188 | 67 | 5 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | PBMC-Mild-Hematopoietic|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.45e-06 | 188 | 67 | 5 | e3d9919eafc6181d2145b9d36f47066d0e22a8bd | |
| ToppCell | PBMC-Mild-Hematopoietic|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.45e-06 | 188 | 67 | 5 | 6bd9317be8918da639254f4bdd432647c43ba9b1 | |
| ToppCell | mild_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 9.70e-06 | 189 | 67 | 5 | 038ec3c266b89416bb5b774ba522d916394961da | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.95e-06 | 190 | 67 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.95e-06 | 190 | 67 | 5 | 726aeb280ea911f3551b18e388c4f7580ae2ea74 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.95e-06 | 190 | 67 | 5 | 50ea3ff7ba1ca335b4e4538fae5f9b74b1fc10f7 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.95e-06 | 190 | 67 | 5 | a1f8757dc719ed030f67d65735358a8d7a407bad | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.95e-06 | 190 | 67 | 5 | c4f55f5a0c42aeb571791925ea80e02fac320608 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 9.95e-06 | 190 | 67 | 5 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | mild_COVID-19-Platelet|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.02e-05 | 191 | 67 | 5 | 968e2d48969884dd21b8a87f199af94a7410b0dd | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-MK-MK|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 192 | 67 | 5 | b877d14be9d04ab0010e340909e3a23de92613db | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 136 | 67 | 4 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 136 | 67 | 4 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 136 | 67 | 4 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 136 | 67 | 4 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.28e-05 | 136 | 67 | 4 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 164 | 67 | 4 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 164 | 67 | 4 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-04 | 166 | 67 | 4 | d1c61270c7b39bb365020eeafe298a8f88aa887e | |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.25e-04 | 170 | 67 | 4 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.28e-04 | 171 | 67 | 4 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet-Megakaryocyte/Platelet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-04 | 172 | 67 | 4 | d0c3fb48c61762dcefca858cf13c9da8eb6d0f5e | |
| ToppCell | cellseq-Immune-Hematopoietic-Megakaryocyte/Platelet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.31e-04 | 172 | 67 | 4 | eb2915165cab2660511e4b70c3a6d3ab2f770809 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 67 | 4 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 174 | 67 | 4 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-04 | 177 | 67 | 4 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.46e-04 | 177 | 67 | 4 | 0830944c43de300815831a9e2b2fce40965e7d12 | |
| ToppCell | (9)_Platelet|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.46e-04 | 177 | 67 | 4 | e63d01c7fce4fa1256212fa7e95f74281edb3a01 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 178 | 67 | 4 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-04 | 178 | 67 | 4 | f5d83ad082e31d5601890d245b9fb4f9ef6a062b | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.49e-04 | 178 | 67 | 4 | a2a8fc14f492a4695e6991a357b6626145f1bf7f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 178 | 67 | 4 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-04 | 179 | 67 | 4 | 510927794bbd21814eba75286e0801eb1fd2e8a6 | |
| ToppCell | PBMC-Convalescent-Hematopoietic|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.53e-04 | 179 | 67 | 4 | 3b1616e974ea7792ff5c37da3b0281f28edfbb56 | |
| ToppCell | PBMC-Convalescent-Hematopoietic|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-04 | 179 | 67 | 4 | 35271a4396a533f6d960ce55d171a32d9d2fd1a4 | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-04 | 179 | 67 | 4 | 906a5ebbbac660b6fd498ced09d0ada40a3e64af | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.53e-04 | 179 | 67 | 4 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_Mega-Platelet|COVID-19_Convalescent / Disease group, lineage and cell class | 1.56e-04 | 180 | 67 | 4 | deed53167504c91220b35a63366ed7d8f02a5254 | |
| ToppCell | COVID-19_Convalescent-Hematopoietic_Mega|COVID-19_Convalescent / Disease group, lineage and cell class | 1.56e-04 | 180 | 67 | 4 | 17323d382ae322e388e230fdad13e3464ea73e8e | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 181 | 67 | 4 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-04 | 181 | 67 | 4 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.59e-04 | 181 | 67 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 182 | 67 | 4 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | remission-Platelet|remission / disease stage, cell group and cell class | 1.63e-04 | 182 | 67 | 4 | 65e2798aacd670cbc3a8c8e9d1a2f7768513bb70 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 182 | 67 | 4 | 975f6275777fc578eba528e50f69891c66ec44ad | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.63e-04 | 182 | 67 | 4 | f8c28fa76751062c4cfba0db8af1b377f947f739 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 184 | 67 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-MK-MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.70e-04 | 184 | 67 | 4 | ba65e3972b2b8d825a2c1a9d03d092cc1afad073 | |
| ToppCell | control-Others|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.70e-04 | 184 | 67 | 4 | a63b39fcc570b554cf10e8e47c2c1e079034768f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 184 | 67 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 184 | 67 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.70e-04 | 184 | 67 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | control-Others-Megakaryocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.70e-04 | 184 | 67 | 4 | 213915f2889ce8ecbe5f7b19bc2b24ed8c5efe1d | |
| ToppCell | megakaryocytic|World / Lineage and Cell class | 1.70e-04 | 184 | 67 | 4 | b1c630ca2189d9d49402a5621b57618976fbea5c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-04 | 185 | 67 | 4 | 9bff336510c80cd762b4e41b4570475033e709ca | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-04 | 185 | 67 | 4 | 452d49c7835a4d55e41caefa44dac5cab30e7ced | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic-Megakaryocyte|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-04 | 185 | 67 | 4 | 53f5136ee1bd101dd5ac8a2c9e63b0c3b987657e | |
| ToppCell | PBMC-Control-Hematopoietic|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-04 | 185 | 67 | 4 | c95c77d4302d7fff7fdef1774f15a93ba9ced61a | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.73e-04 | 185 | 67 | 4 | 0a2c8ce92a257d0ec5bcc8efa22792d53752c665 | |
| ToppCell | PBMC-Control-Hematopoietic|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-04 | 185 | 67 | 4 | 72a281ef246de5b30de1241d792c25bfae60e797 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.73e-04 | 185 | 67 | 4 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Hematopoietic-Megakaryocytic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.73e-04 | 185 | 67 | 4 | 67ac5c2bacdbdcb40ee65c44da55b3f597b410ee | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.77e-04 | 186 | 67 | 4 | 3bf38c80d892a73391009b426dec8ae26a027351 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.77e-04 | 186 | 67 | 4 | 7496137cebc191aecd1e6ae7fa33118b128fbfe6 | |
| ToppCell | Megakaryocytic-erythropoietic-Megakaryo-cells-Platelet|World / Lineage, cell class and subclass | 1.77e-04 | 186 | 67 | 4 | 27807334e7241c8a9aeaf6403f0fd0b001fbc0d1 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 186 | 67 | 4 | 4a9b5b3a56229629161d5404db2b8dd76e10cf4b | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 186 | 67 | 4 | 9c2fd0bbc968c317a763f52e72fa7182c3c49850 | |
| ToppCell | megakaryocytic-Megakaryocyte|World / Lineage and Cell class | 1.77e-04 | 186 | 67 | 4 | acd15a169b6122b28cc99ef34de10701edcfedfe | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 186 | 67 | 4 | 06281df5e9665ccc510279bf7e552845c63d5dab | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 186 | 67 | 4 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-04 | 186 | 67 | 4 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-04 | 186 | 67 | 4 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-04 | 187 | 67 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Control-Hematopoietic_Mega-Platelet|Control / Disease group, lineage and cell class | 1.81e-04 | 187 | 67 | 4 | 53e9665e1feb02ce8fe78ff4128fd4beacef8471 | |
| ToppCell | severe-Platelet|World / disease stage, cell group and cell class | 1.81e-04 | 187 | 67 | 4 | 72475fb6d053354b581e61c6eee3719a7dd08c8b | |
| ToppCell | Control-Hematopoietic_Mega|Control / Disease group, lineage and cell class | 1.81e-04 | 187 | 67 | 4 | 7bf98bdc83feb3918dbcf12e87a64fe4d2d41eba | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.81e-04 | 187 | 67 | 4 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | remission-Platelet|World / disease stage, cell group and cell class | 1.84e-04 | 188 | 67 | 4 | fa69f20ef6b8ce620ba342f0984d40ddf259bc3f | |
| ToppCell | Healthy/Control-Platelet|World / Disease group and Cell class | 1.84e-04 | 188 | 67 | 4 | 552077e4597d0956f4d8c40c9de8f109e87cb857 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-04 | 188 | 67 | 4 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | severe_influenza-Platelet|World / disease group, cell group and cell class (v2) | 1.84e-04 | 188 | 67 | 4 | b54632baa682aaf51100d44e7f114a54d5edd695 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.88e-04 | 189 | 67 | 4 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.88e-04 | 189 | 67 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | Multiciliated|World / shred by cell class for nasal brushing | 1.88e-04 | 189 | 67 | 4 | 34b110aef839376228c5a403a6b5047a945f472b | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.88e-04 | 189 | 67 | 4 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Healthy-Platelet|Healthy / disease group, cell group and cell class | 1.88e-04 | 189 | 67 | 4 | 5863e132536594e49bffbb637454cc43dfdbaa20 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.88e-04 | 189 | 67 | 4 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-04 | 190 | 67 | 4 | b719061be370ffc293854f1f6e526bf33cd2f442 | |
| ToppCell | COVID-19_Moderate-Platelet|World / disease group, cell group and cell class | 1.92e-04 | 190 | 67 | 4 | 6e4f4af5ba185bb022753881a26a269a544bb59b | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-04 | 190 | 67 | 4 | 427038bae9c7b3a9441c8d59ace69da74e9d37bf | |
| ToppCell | COVID-19_Moderate-Platelet|COVID-19_Moderate / disease group, cell group and cell class | 1.92e-04 | 190 | 67 | 4 | 3bf4ab3fd3a391da98a83e2aac0881a0e5c8f8b0 | |
| ToppCell | severe-Platelet|severe / disease stage, cell group and cell class | 1.92e-04 | 190 | 67 | 4 | 497ec3fe4dd6f1b4fa6e76d9ac07df497efce7a2 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.96e-04 | 191 | 67 | 4 | 7da172553ed6df4a0c34ecd55665a9598b5071a5 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.96e-04 | 191 | 67 | 4 | 1a1bf85bc77bf093a0ac2cb9eabaeac820a7b93e | |
| ToppCell | COVID-19_Mild-Hematopoietic_Mega-Platelet|COVID-19_Mild / Disease group, lineage and cell class | 1.96e-04 | 191 | 67 | 4 | 6b3cfc670f69ed3e757cbf7498943e549e31326e | |
| ToppCell | ASK428-Epithelial-Ciliated|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.96e-04 | 191 | 67 | 4 | 0c4b926a28bc94f3cf4d68a911c0a189f6ff505e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-04 | 191 | 67 | 4 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| Drug | dexamethasone; Up 200; 1uM; MCF7; HG-U133A | 1.83e-06 | 197 | 67 | 7 | 255_UP | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; PC3; HT_HG-U133A | 1.92e-05 | 188 | 67 | 6 | 3823_UP | |
| Drug | Simvastatin [79902-63-9]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.16e-05 | 192 | 67 | 6 | 4244_UP | |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; PC3; HT_HG-U133A | 2.36e-05 | 195 | 67 | 6 | 4063_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 5577_UP | |
| Drug | Mephenytoin [50-12-4]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.43e-05 | 196 | 67 | 6 | 6158_UP | |
| Drug | indomethacin, USP; Down 200; 20uM; MCF7; HG-U133A | 2.43e-05 | 196 | 67 | 6 | 262_DN | |
| Drug | dansylputrescine | 2.55e-05 | 3 | 67 | 2 | CID000598792 | |
| Drug | Ebselen [60940-34-3]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 5778_UP | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.57e-05 | 198 | 67 | 6 | 4805_DN | |
| Drug | 2-methyl-3-hydroxybutyryl-CoA | 4.14e-05 | 23 | 67 | 3 | CID000000052 | |
| Drug | Hydroxocobalamin | 5.10e-05 | 4 | 67 | 2 | ctd:D006879 | |
| Drug | cyclopentene oxide | 5.10e-05 | 4 | 67 | 2 | CID000009244 | |
| Disease | Schizophrenia | 2.21e-05 | 883 | 65 | 10 | C0036341 | |
| Disease | Bipolar Disorder | 8.56e-05 | 477 | 65 | 7 | C0005586 | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 2.13e-04 | 10 | 65 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | Global developmental delay | 2.16e-04 | 133 | 65 | 4 | C0557874 | |
| Disease | Intellectual Disability | 4.54e-04 | 447 | 65 | 6 | C3714756 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.62e-04 | 68 | 65 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | breast milk measurement | 1.67e-03 | 106 | 65 | 3 | EFO_0009092 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVMGLMLGKVDGETM | 76 | Q92905 | |
| MLGKVDGETMIIMDS | 81 | Q92905 | |
| QVIEDFIHIVGMGMM | 676 | O60242 | |
| REDMEGMLGEDVMRA | 76 | Q96DY2 | |
| ISMGMTDPEMVEVHA | 2301 | Q12802 | |
| QEVVMGGMVLETNMN | 121 | P59780 | |
| TQGLDMSGVFMEMVK | 41 | Q9Y6B7 | |
| AASEDMEPVNMESMG | 21 | Q8IWG1 | |
| DLMSDAMEEIDMQQG | 1411 | Q96BY7 | |
| GSVEMMNVESKGMRD | 836 | Q5TC82 | |
| MNGVAGDGMINIDMT | 51 | P11161 | |
| AGEEGMIEDMKLMFR | 581 | Q86U86 | |
| DAREQEIRMGQMAMG | 376 | Q15233 | |
| MMEIQMDEGGGVVVY | 1 | Q9UPT6 | |
| REFMVMEGMSLVIDT | 1196 | Q5SZK8 | |
| ILSEMGEVTDGMMDT | 301 | Q96A33 | |
| EMGVMPEIAQAVEEM | 6 | Q92499 | |
| MMGVLDGVLMELQDC | 46 | P40925 | |
| GSMSSMEVNVDMLEQ | 226 | Q96EV8 | |
| ACMMQEVGVEDTPLM | 121 | P01569 | |
| SSQKMDGMGIEMIDE | 2981 | P24043 | |
| DGMGIEMIDEKLMFH | 2986 | P24043 | |
| LDMMEIAGQVQVDGE | 501 | Q02153 | |
| EEDQMMRAIAMSLGQ | 1371 | Q7Z6Z7 | |
| VLGMDMGLREMCVGE | 426 | O95302 | |
| SEVLGMDAGEMVIQM | 281 | Q7Z4Q2 | |
| LEESMGAVQMGLVNM | 6 | Q4G0P3 | |
| NIDEEASMMEDVGMQ | 1691 | Q9BZ29 | |
| EQMMLASMREVIGLG | 1251 | Q8TD57 | |
| MDCGGMLIEMQEEVK | 441 | P54257 | |
| TLDAMIMDGTTMDVG | 86 | P20933 | |
| MGDDMVQEPGLVMIF | 296 | Q9H4P4 | |
| ERRGVGAMEIVAMDM | 511 | A3KN83 | |
| GMHETVMEVMVNVLG | 2166 | Q92736 | |
| NGVQMMTFDSEVELM | 126 | P11926 | |
| GVVEDMGGEVQNMLE | 61 | Q8IZU3 | |
| MEDMRNIEMVEGGEG | 686 | Q2TB90 | |
| NEEMMIGEAMAETGH | 2021 | Q5UIP0 | |
| EMAPGGVITSDMIEM | 76 | P52294 | |
| MPVSEMAEDGSEEIM | 296 | P57071 | |
| EALMMEEEGMVIVGL | 241 | Q96T51 | |
| MVLDGGMGTMIQREK | 31 | Q99707 | |
| TGLMEATQMMVDIDG | 596 | Q9BYZ6 | |
| EEGPEAREMAMMQEG | 391 | Q9UL54 | |
| EKRGVGAMEIVAMDM | 456 | Q9Y2G9 | |
| DVMVAGGMESMSNVP | 146 | P24752 | |
| MFELMEDLQGMGESN | 251 | Q5TEU4 | |
| DGMITLDDMEEMDGL | 371 | Q96QV1 | |
| MDIAMLVENQGEMLD | 216 | Q13277 | |
| DECIQIMGGMGFMKE | 431 | P49748 | |
| MMETMDQGDVIIRPS | 1346 | Q7KZ85 | |
| NMMEESEMCAVPGGL | 66 | A4UGR9 | |
| QAEALMLVMEMAGGG | 406 | P43403 | |
| MAGIEITEEMTMEQL | 686 | Q8NI27 | |
| ITEEMTMEQLEAMTG | 691 | Q8NI27 | |
| VDMAMLVESQGEMID | 216 | P61266 | |
| MDIGLDSQDPMMELT | 601 | Q8N1W2 | |
| MGIGVDTIDMVMAAQ | 781 | Q5SRE5 | |
| MTELETAMGMIIDVF | 1 | P25815 | |
| EDGALMDGGMDLNME | 81 | Q9BTX3 | |
| GITKMNMNVMEEAIG | 841 | Q96AY4 | |
| MAEVVAEVAEMPTQM | 1 | Q8TF50 | |
| MEMSTEVTEMTPGEA | 31 | Q8TF50 | |
| QDAVMGQDLMVSVML | 586 | P22735 | |
| EGNMEEEEMNDGSQM | 11 | Q8N859 | |
| VEMMAQLLGIMVVAS | 241 | P21731 | |
| TLDMPVGMTHGLMEQ | 81 | O94842 | |
| MNMEGLVMFQDLSID | 1 | A8MQ14 | |
| EEMNGINSIEMDSMR | 241 | O94782 | |
| ESEMQDMMTRGNLGL | 366 | Q01538 | |
| MMGELLSGQADMIVA | 501 | Q05586 |